Novonesis (Novozymes) A/S (NSIS-B) — Long-term Investment Intensity
Novonesis (Novozymes) A/S (NSIS-B) has a Long-term Investment Intensity of 0.3% as of December 2019. Long-term investments of Dkr59.00 Million represent 0.3% of total assets of Dkr20.44 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See NSIS-B total equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Novonesis (Novozymes) A/S Long-term Investment Intensity (2013–2019)
This chart shows how Novonesis (Novozymes) A/S's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 0.3%, reflecting long-term investments of Dkr59.00 Million against total assets of Dkr20.44 Billion DKK. Also explore balance sheet size of Novonesis (Novozymes) A/S for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Novonesis (Novozymes) A/S (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for Novonesis (Novozymes) A/S from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see NSIS-B company net worth.
| Year | LT Investment Intensity | LT Investments (DKK) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 0.3% | Dkr59.00 Million | Dkr20.44 Billion | ▼ 0.0 pp |
| 2018 | 0.3% | Dkr62.00 Million | Dkr19.70 Billion | ▼ -0.2 pp |
| 2017 | 0.5% | Dkr88.00 Million | Dkr18.37 Billion | ▼ -0.7 pp |
| 2016 | 1.2% | Dkr224.00 Million | Dkr18.66 Billion | ▼ -0.1 pp |
| 2015 | 1.3% | Dkr230.00 Million | Dkr17.79 Billion | ▲ +1.0 pp |
| 2014 | 0.3% | Dkr53.00 Million | Dkr18.43 Billion | ▼ -0.1 pp |
| 2013 | 0.4% | Dkr59.00 Million | Dkr16.51 Billion | — |